X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse J.B.Chemicals with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ACTAVIS (US) - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 J.B.CHEMICALS   ACTAVIS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ACTAVIS
Dec-14
J.B.CHEMICALS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs31818,583-   
Low Rs20011,335-   
Sales per share (Unadj.) Rs148.03,346.3-  
Earnings per share (Unadj.) Rs19.1-417.6-  
Cash flow per share (Unadj.) Rs23.9307.0-  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.97,258.0-  
Shares outstanding (eoy) m84.82265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.5 39.1%   
Avg P/E ratio x13.6-35.8 -37.9%  
P/CF ratio (eoy) x10.848.7 22.2%  
Price / Book Value ratio x2.02.1 97.4%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9513,977,639 0.6%   
No. of employees `0002.721.6 12.7%   
Total wages/salary Rs m1,8410-   
Avg. sales/employee Rs Th4,590.941,193.7 11.1%   
Avg. wages/employee Rs Th673.40-   
Avg. net profit/employee Rs Th592.1-5,140.5 -11.5%   
INCOME DATA
Net Sales Rs m12,551889,783 1.4%  
Other income Rs m542-2,221 -24.4%   
Total revenues Rs m13,093887,563 1.5%   
Gross profit Rs m2,055114,305 1.8%  
Depreciation Rs m412192,671 0.2%   
Interest Rs m9628,065 0.3%   
Profit before tax Rs m2,088-108,651 -1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,970 0.0%   
Tax Rs m469-5,586 -8.4%   
Profit after tax Rs m1,619-111,036 -1.5%  
Gross profit margin %16.412.8 127.4%  
Effective tax rate %22.55.1 436.9%   
Net profit margin %12.9-12.5 -103.3%  
BALANCE SHEET DATA
Current assets Rs m7,778468,802 1.7%   
Current liabilities Rs m4,358341,894 1.3%   
Net working cap to sales %27.214.3 191.0%  
Current ratio x1.81.4 130.2%  
Inventory Days Days5558 94.2%  
Debtors Days Days8066 120.7%  
Net fixed assets Rs m5,713108,651 5.3%   
Share capital Rs m1700-   
"Free" reserves Rs m10,5470-   
Net worth Rs m10,9371,929,908 0.6%   
Long term debt Rs m01,011,310 0.0%   
Total assets Rs m15,5743,536,886 0.4%  
Interest coverage x22.8-2.9 -794.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.3 320.4%   
Return on assets %11.0-2.3 -469.3%  
Return on equity %14.8-5.8 -257.2%  
Return on capital %20.0-3.0 -663.1%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Net fx Rs m4,8840-   
CASH FLOW
From Operations Rs m1,397152,793 0.9%  
From Investments Rs m-320-365,845 0.1%  
From Financial Activity Rs m-1,196205,552 -0.6%  
Net Cashflow Rs m-102-7,500 1.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 68.12 Rs / USD

Compare J.B.CHEMICALS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare J.B.CHEMICALS With: DR. REDDYS LAB  PIRAMAL ENTERPRISES  FULFORD INDIA  PANACEA BIOTECH  TORRENT PHARMA  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 20, 2018 03:37 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS